Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroblastoma × vandetanib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 10 Carcinoma, Medullary 9 Thyroid Neoplasms 7 Lung Neoplasms 6 Neoplasm Metastasis 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Carcinoma, Renal Cell 3 Prostatic Neoplasms 2 Kidney Neoplasms 2 Gliosarcoma 2 Glioblastoma 2 Familial medullary thyroid carcinoma 2 Fallopian Tube Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid cancer, medullary 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Oligodendroglioma 1 Multiple Endocrine Neoplasia Type 2b 1 Multiple Endocrine Neoplasia Type 2a 1

Interventions

Cyclophosphamide 20 Isotretinoin 14 Topotecan 12 Irinotecan 12 Etoposide 12 Temozolomide 10 Doxorubicin 10 dinutuximab 9 Magnetic Resonance Spectroscopy 9 sargramostim 8 Vincristine 8 Melphalan 8 Filgrastim 7 Cisplatin 7 Granulocyte-Macrophage Colony-Stimulating Factor 6 Granulocyte Colony-Stimulating Factor 6 3-Iodobenzylguanidine 6 Specimen Handling 5 Carboplatin 5 fludarabine 4 etoposide phosphate 4 aldesleukin 4 X-Rays 4 Stem Cell Transplantation 4 Radiotherapy 4 Phantoms, Imaging 4 Mesna 4 Colony-Stimulating Factors 4 Busulfan 4 Biopsy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡